Vanda Pharmaceuticals (VNDA) financials · rev $216.1M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Vanda Pharmaceuticals (VNDA) rev $216.1M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $216.1M | $198.8M |
| Operating Income | -$151.2M | -$40.7M |
| Net Income | -$220.5M | -$18.9M |
| EPS (Diluted) | -$3.74 | -$0.33 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $488.9M | $656.2M |
| Current Assets | $347.3M | $438.9M |
| Cash & Equivalents | $84.9M | $102.3M |
| Inventory | $1.85M | $1.73M |
| PP&E | $2.25M | $2.13M |
| Total Liabilities | $161.8M | $117.7M |
| Current Liabilities | $145.2M | $100.0M |
| Shareholders' Equity | $327.2M | $538.5M |
| Retained Earnings | -$394.8M | -$174.3M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$109.4M | -$15.8M |
| CapEx | $998.0K | $490.0K |
| Investing Cash Flow | $94.9M | -$17.4M |
| Financing Cash Flow | -$2.91M | -$155.0K |
| Net Change in Cash | -$17.5M | -$33.5M |
| Free Cash Flow | -$110.4M | -$16.2M |
FAQ
What is VNDA P/E and revenue?
Vanda Pharmaceuticals (VNDA) rev $216.1M.
What is VNDA revenue?
Vanda Pharmaceuticals last cached revenue is $216.1M (FY2025).
Is VNDA profitable?
Vanda Pharmaceuticals last cached net income is -$220.5M (FY2025).
What are VNDA total assets?
Vanda Pharmaceuticals last cached total assets are $488.9M (FY2025).
What is VNDA free cash flow?
Vanda Pharmaceuticals last cached free cash flow is -$110.4M (FY2025).
Not investment advice. Cached statements, not a live tape.